UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a funding opportunity from UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, up to 14499067, closing July 31, 2029.
Jul 31, 2029
(1096d left)Overview
PROJECT SUMMARY / ABSTRACT Progressive Supranuclear Palsy (PSP) is a severe neurodegenerative disease of aging that usually leads to death within 5-7 years of diagnosis. There are no effective treatments for PSP, but therapeutic approaches being tested in clinical trials for other neurodegenerative diseases, such as…